Hyo-Min Shin

Hyo-Min Shin

Auto-generated profile, based on publicly available information

Hyo-Min Shin

Department of Neurology, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, South Korea

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2022 in Journal of Health Informatics and Statistics
Verified
Journal Article
Open access
PDF file
HSHyo-Min Shin
Hyo-Min Shin
SLSang-Jun Lee
Sang-Jun Lee
WKWoo-Rim Ko
Woo-Rim Ko
JJJae-Yeon Jeong
Jae-Yeon Jeong
Sang-Baek KohSang-Baek Koh
Sang-Baek Koh
Kyung-Yi DoKyung-Yi Do
Kyung-Yi Do
GAD, Generalized Anxiety Disorder; SE, standard error.

17 April 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
HSHyomin Shin
Hyomin Shin
WHWoo Seok Ha
Woo Seok Ha
JKJaeho Kim
Jaeho Kim
SPSang Hyun Park
Sang Hyun Park
KHKyungdo Han
Kyungdo Han
Min Seok BaekMin Seok Baek
Min Seok Baek
Objective: We aimed to examine the potential association between migraine and vascular dementia (VaD) using a nationwide population database. Background: Migraine and VaD showed similar structural and functional changes in pathophysiology process and shared common risk factors, However, whether migraine prevalence increases VaD incidence remains controversial. Methods: This retrospective population-based cohort study used the medical records from the Korean National Health Insurance System database. Migraine (G43) was defined by using the Tenth Revision of the International Classification of Diseases code. More than two migraine diagnoses at least 3 months apart were defined as “chronic migraine”. Cox proportional hazards model estimated hazard ratios (HRs) of VaD for group comparisons. Results: We included 212,836 patients with migraine and 5,863,348 individuals without migraine. During 10 years of follow-up, 3,914 (1.8%) and 60,258 (1.0%) patients with and without migraine, respectively, were newly diagnosed with VaD. After adjustment, patients with migraine showed a 1.21-fold higher risk of VaD than those without migraine (HR = 1.21; 95% confidence interval (CI): 1.17–1.25). Patients with chronic migraine showed a higher cumulative incidence of VaD than those with episodic migraine. The adjusted HR for the VaD incidence with migraine was higher in: (1) patients aged <65 years; (2) women; (3) patients without hypertension, diabetes, or atrial fibrillation; and (4) non-smokers. Conclusion: Migraine is associated with an increased risk of VaD, particularly in chronic migraine patients. Incidence of VaD in the setting of migraine may have distinct pathophysiology from that of VaD with traditional cardiovascular risks.